ENTASIS THERAPEUTICS
Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Entasisโ anti-infective discovery platform has produced a pipeline of meaningfully differentiated programs which target serious bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), and zoliflodacin (targeting Neisseria gonorrhoeae).
ENTASIS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.entasistx.com
Total Employee:
11+
Status:
Active
Contact:
(781)810-0120
Email Addresses:
[email protected]
Total Funding:
199.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Centerline Biomedical
Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system
Cortexyme
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Enlibrium
Enlibrium is a developing novel drugs
IMTherapeutics
IM Therapeutics develops personalized immuno-therapeutic drugs.
Phyla
Phyla is developing alternative therapies for antibiotics.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CARB-X
CARB-X investment in Grant - Entasis Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Entasis Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Entasis Therapeutics
TPG
TPG investment in Series B - Entasis Therapeutics
CARB-X
CARB-X investment in Grant - Entasis Therapeutics
Eventide
Eventide investment in Series B - Entasis Therapeutics
Clarus Ventures
Clarus Ventures investment in Series B - Entasis Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Entasis Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Entasis Therapeutics
Official Site Inspections
http://www.entasistx.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.31 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109